Sort
141,003 grants matching “cytokine”
Harnessing the CARD8 Inflammasome for HIV Reservoir Elimination
$797,024Liang Shan · Washington University · R01 · FY2024 · AI
Harnessing the CARD8 Inflammasome for HIV Reservoir Elimination
$797,024Marilia Rita Pinzone · Washington University · R01 · FY2025 · AI
Drug-eluting fibers for on-demand and extended protection against HIV
$797,023Kim A. Woodrow · University Of Washington · R01 · FY2022 · AI
Targeted Gene Delivery Systems Treating Lung Diseases
$797,003Matthew Tirrell · University Of Chicago · R01 · FY2025 · HL
Targeted Gene Delivery Systems Treating Lung Diseases
$797,003Matthew Tirrell · University Of Chicago · R01 · FY2022 · HL
Targeted Gene Delivery Systems Treating Lung Diseases
$797,003Matthew Tirrell · University Of Chicago · R01 · FY2023 · HL
Functional impact of IL33 polymorphisms on asthma & other Th2-mediated diseases
$796,936Kathleen C Barnes · Johns Hopkins University · R01 · FY2012 · HL
Mechanisms of Fibrosis in Asthma and Other Fibroproliferative Diseases
$796,846Thomas Wynn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Contextual and Health Behavior Effects on Epigenetic Aging Among African Americans
$796,841Frederick X Gibbons · University Of Connecticut Storrs · R01 · FY2020 · CA
Preclinical Development of the TAK1 Inhibitor HS-276 for the Treatment of Rheumatoid Arthritis
$796,786Scott Scarneo · Eydis Bio, Inc. · R44 · FY2021 · AR
Fatigue, depression, and inflammation in cancer survivors: A prospective study
$796,786Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2011 · CA
Genetic Engineering of Vein Bypass Grafts in Vascular and Cardiovascular Surgery
$796,784Frank W Logerfo · Beth Israel Deaconess Medical Center · R01 · FY2022 · HL
Inflammatory Challenge in Human Aggression
$796,717Emil F Coccaro · Ohio State University · R01 · FY2025 · MH
URSODIOL-METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS
$796,705University Of Texas Sw Med Ctr/Dallas · R01 · FY2000 · DK
Inflammatory and Glutamatergic Mechanisms of Sustained Threat in Adolescents with Depression: Toward Predictors of Treatment Response and Clinical Course
$796,675Tiffany Cheing Ho · University Of California Los Angeles · R01 · FY2025 · MH
Posttranscriptional control of gene expression
$796,657Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Controlled Release Scaffolds for Nerve Regeneration
$796,640Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2017 · EB
Immunologic changes associated with three progestin-based contraceptives: characterizing immune profiles over one year and identifying factors that may alter HIV risk
$796,600Lisa Blake Haddad · Emory University · R01 · FY2018 · HD
TICIPS: HIV/AIDS, Secondary Infections and Immune Modul*
$796,567William Robert Folk · University Of Missouri-Columbia · U19 · FY2008 · AT
Project 1 - Phase I/II Clinical Trial of L. frutescens in HIV-infected adults
$796,567William Robert Folk · University Of Missouri-Columbia · U19 · FY2008 · AT
The Fetal and Childhood Environment, Oxidative Balance, Inflammation and Asthma
$796,483Diane R Gold · Brigham And Women'S Hospital · R01 · FY2017 · AI
Optimization of a potent and cell active CK2 chemical probe for Alzheimer's disease therapy
$796,443Alison Donnelly Axtman · Univ Of North Carolina Chapel Hill · R56 · FY2025 · AG
eQTL mega-analysis for functional assessment of multi-enhancer gene regulation
$796,375Gregory C. Gibson · Georgia Institute Of Technology · R01 · FY2016 · HG
Effect of Aging on Preadipocyte Differentiation
$796,303James L. Kirkland · Mayo Clinic Rochester · R37 · FY2022 · AG
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV
$796,244Kenneth W Witwer · Johns Hopkins University · R01 · FY2021 · AI